CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Multiple-Dose, Dose Escalation Study To Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Participants With Cervical High Grade Squamous Intraepithelial Lesions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03697226
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:51.705834+00:00
Published At: 2021-01-13T00:00:00+00:00
Record Updated At: 2021-01-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HSIL of Cervix", "HSIL, High Grade Squamous Intraepithelial Lesions", "High-Grade Cervical Intraepithelial Neoplasia", "Human Papilloma Virus", "HIV Negative", "Cervical Cancer", "CIN - Cervical Intraepithelial Neoplasia", "Cervical Neoplasm", "Cervical Dysplasia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-01-13"
protocolSection.identificationModule.nctId: "NCT03697226"
protocolSection.identificationModule.officialTitle: "An Open-Label Multiple-Dose, Dose Escalation Study To Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Participants With Cervical High Grade Squamous Intraepithelial Lesions"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.